Billing & Coding: Myriad Genetics Pays $9.1 Million to Settle Claims of Falsely Billing Medicare for Hereditary Cancer Tests

In March 2018, Myriad Genetics got a piece of mail no lab provider ever wants to see in its inbox: an OIG subpoena asking for billing records in connection with “an investigation into possible false or otherwise improper claims for payment under Medicare and Medicaid.” At issue were claims for what was then Myriad’s new…